Sjs Investment Consulting Inc. Alkermes Plc. Transaction History
Sjs Investment Consulting Inc.
- $534 Million
- Q1 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Alkermes Plc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 23 shares of ALKS stock, worth $666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 23
-0.0%
Holding current value
$666
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ALKS
# of Institutions
409Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$844 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$528 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$342 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$232 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$200 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.76B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...